This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Newman TB, Maisels MJ Kernicterus in otherwise healthy, breast-fed term newborns Pediatrics 1995 96 730–3
Seidman D, Stevenson D, Ergaz Z, et al Hospital readmission due to neonatal hyperbilirubinemia Pediatrics 1995 96 727–9
Maisels MJ, Kring E Early discharge from the newborn nursery — effect on scheduling of follow-up visits by pediatricians Pediatrics 1997 100 71–4
Tenhunen R, Marver HS, Schmid R The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase Proc Natl Acad Sci USA 1969 61 748–55
Drummond GS, Kappas A Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation Proc Natl Acad Sci USA 1981 78 6466–70
Valaes T, Drummond GS, Kappas A Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin Pediatrics 1998 101 1–7
Drummond GS, Galbraith RA, Sardana MK, et al Reduction of the C2 and C4 vinyl groups of Sn-protoporphyrin to form Sn-mesoporphyrin markedly enhances the ability of the metalloporphyrin to inhibit in vivo heme catabolism Arch Biochem Biophys 1987 255 64–74
Valaes T, Petmezaki S, Henschke C, et al Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin Pediatrics 1994 93 1–11
Berglund L, Angelin B, Blomstrand R, et al Sn-protoporphyrin lowers serum bilirubin levels, decreases biliary bilirubin output, enhances biliary heme excretion and potently inhibits hepatic heme oxygenase activity in normal human subjects Hepatology 1988 8 625–31
Kappas A, Drummond GS Control of heme metabolism with synthetic metalloporphyrins J Clin Invest 1986 77 335–9
Martı´nez JC, Garcı´a HO, Otheguy LE, et al Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin Pediatrics 1999 103 1–5
Kappas A, Drummond GS, Manola T, et al Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility Pediatrics 1988 81 485–97
Kappas A, Drummond GS, Henschke CI, et al Direct comparison of Sn-mesoporphtyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns Pediatrics 1995 95 468–74
Martı´nez JC, Maisels MJ, Otheguy LE, et al Hyperbilirubinemia in the breastfed-newborn: a controlled trial of four interventions Pediatrics 1993 91 470–3
Kemper K, Forsyth B, Mc Carthy P Jaundice, terminating breast-feeding and the vulnerable child Pediatrics 1989 84 773–8
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
César Martínez, J., García, H., Otheguy, L. et al. Treatment of Hyperbilirubinemia Pharmacologic Approach SnMP(Tin-Mesoporphyrin). J Perinatol 21 (Suppl 1), S101–S103 (2001). https://doi.org/10.1038/sj.jp.7210655
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.jp.7210655